At the system level, IFN-γ–driven metabolic reprogramming of macrophages requires HIF-1α; myeloid HIF-1α deficiency worsens TB in mice, nominating HIF-1α–regulated transcripts as treatment response biomarkers (Braverman et al., 2016). This evidence concerns the gene IFNG and tuberculosis.